Navigation Links
Mehr Law Group Announces Campaign to Help Consumers Injured During Dialysis
Date:2/3/2013

(PRWEB) February 03, 2013

The product liability attorneys Mehr Law Group announced a new campaign today to help consumers injured as a result of their dialysis treatment. Consumers who have believe they have been injured as a result of their dialysis treatment are encouraged to call the Mehr Law Group to obtain a free consultation and information on how they can help.

Across America, 400,000 Americans receive dialysis treatment per year in a variety of care centers. 1/3 of these patients receive dialysis treatment using Fresenius Medical Care’s dialysis concentrates, GranuFlo® and NaturaLyte®. During dialysis treatment, these acid concentrates were commonly mixed with bicarbonates to lower the amount of acid build up in the blood to prevent kidney failure. Because these acid concentrates already had elevated bicarbonate levels, patients were at risk for alkalosis, which could cause severe injuries such as heart attacks.

In 2010, doctors in Fresenius’ Medical Centers observed over 900 patients’ heart attacks during dialysis treatment. These injuries were disclosed in an internal health communication (disclosed in this NY Times article here: http://www.nytimes.com/2012/06/15/health/fda-investigates-fresenius-for-failure-to-warn-of-risk.html?_r=0) Company- wide, doctors received new dosage instructions to alleviate the concern for heart attacks, but this memo and updated health care information was not distributed outside of the network.

The U.S. Food and Drug Administration (FDA) recalled both GranuFlo® and NaturaLyte® in March, 2012 amid concerns for the high potential for dialysis injury, namely heart attacks during or after dialysis treatment. In this Class 1 recall, the FDA required Fresenius Medical Care to urgently issue a product communication warning doctors outside of their network of updated dosage recommendations. (Recall available here: http://www.fda.gov/MedicalDevices/Safety/ListofRecalls/ucm309990.htm)

Said attorney Steve Mehr,” We’ve received numerous calls from family members who lost a loved one to a heart attack during their dialysis treatment. We’d like to listen and learn more about patients’ alleged dialysis injuries. And we’d like to offer our help to compensate these families for these shocking alleged dialysis injuries.”

Consumers who suspect they or a loved one has suffered injury as the result of their dialysis treatment are encouraged to call the Mehr Law Group today to gain the help they need. (800) 908-8124

About Mehr Law Group:
Mehr Law Group is a premiere product liability and personal injury law firm. Operating in Irvine, California, the Mehr Law Group has recovered hundreds of millions of dollars on behalf of injured clients. Their decades of experience and compassion towards clients make the Mehr Law Group stand apart from the rest. Consumers who have suffered injury are encouraged to call (800) 908-8124 today for a free case evaluation. http://mehrlawgroup.com/dangerous-drugs/granuflor-and-naturalyter

Read the full story at http://www.prweb.com/releases/2013/2/prweb10390389.htm.


'/>"/>
Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Related medicine news :

1. Maiden Media Group Certified as Minority Business Enterprise in Philadelphia
2. Group Therapy: New approach to psychosis treatment could target multiple nervous system receptors
3. Fish Like Grouper, Barracuda May Pose Food-Poisoning Risk
4. The US Drug Watchdog Now Urges Young Women Who Suffered a Heart Attack or Blood Clotting After Taking Yaz or Yasmin Birth Control Pills to Contact the Johnson Law Group
5. US Drug Watchdog Now Urges Family Members Of Diabetics Who Used the Diabetes Drug Actos and Then Were Diagnosed with Bladder Cancer to Call The Johnson Law Group ASAP
6. Cunningham Financial Group Encourages Women to Celebrate “Cervical Health Awareness Month” by Following Important Health Tips
7. US Drug Watchdog is Now Urging Bladder Cancer Victims to Call the Johnson Law Group if They Used Diabetes Drug Called Actos Prior to Diagnosis
8. Dr. Andy Chiou elected President and Chief Executive Officer of Peoria Surgical Group, Ltd.
9. Ob/Gyn Group Urges Docs to Help Prevent Octomom-Type Multiple Births
10. The Boston Eye Group Implants First Intraocular Pressure Transducer for Glaucoma Monitoring
11. US Drug Watchdog Now Urges Users of Yaz Yasmin Birth Control Pills That Had a Stroke Or Developed Other Serious Medical Conditions to Contact The Johnson Law Group
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/11/2016)... ... February 11, 2016 , ... The ... candidates for the Board of Commissioners. Individuals interested in volunteer board service are ... diversity of clinical practice settings and across allied health to contribute to its ...
(Date:2/11/2016)... SURPRISE, ARIZ. (PRWEB) , ... February 11, 2016 , ... ... kids,” a group of men, 60 and older, who gather once a year to ... , Besides a love for the game, the more than 50 players who competed ...
(Date:2/11/2016)... ... February 11, 2016 , ... AccuVein Inc. ... Infusion Therapy Standards of Practice, to include vascular visualization as a standard practice. ... 85% share of the market, facilitates adherence to this standard with its easy ...
(Date:2/11/2016)... ... February 11, 2016 , ... Dickinson Insurance & Financial Services ... a new fundraiser in support of a local boy named Barrett, who has been ... bring awareness to, and rally support for, all local families dealing with childhood cancer. ...
(Date:2/11/2016)... ... ... Be Well Medical Group (Be Well) is pleased to announce the ... Columbus St, Suite 201, Alexandria, VA. Be Well Medical Group is a concierge practice ... their homes, offices or at the practices’ local office. It is also one of ...
Breaking Medicine News(10 mins):
(Date:2/10/2016)... , February 11, 2016 ... of the "Molecular Diagnostics Reports Bundle" ... http://www.researchandmarkets.com/research/rp4pg8/molecular ) has announced the addition ... report to their offering. --> ... has announced the addition of the ...
(Date:2/10/2016)... REDWOOD CITY, Calif., Feb. 10, 2016   Genomic Health, Inc. ... progress for the quarter and year ended December 31, 2015. ... in the fourth quarter of 2015, compared with $69.1 million in ... a constant currency basis, revenue increased 9 percent compared with the ... --> U.S. revenue was $63.9 million in the fourth ...
(Date:2/10/2016)... -- Vanda Pharmaceuticals Inc. (Vanda) (NASDAQ: VNDA ), ... quarter and full year ended December 31, 2015. ... a transformational year for Vanda with the continued growth ... approval of HETLIOZ for Non-24," said Mihael H. Polymeropoulos, ... to our U.S. product portfolio builds on this success ...
Breaking Medicine Technology: